Skip to main content
HKPD
NASDAQ Trade & Services

Cellyan Biotechnology Secures $6.5M in Highly Dilutive Private Placement with Warrants

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
9
Price
$0.62
Mkt Cap
$7.26M
52W Low
$0.576
52W High
$2.76
52W Position info
7.6% above low
Off High info
78% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HKPD is trading near its 52-week low of $0.576 (7.6% above the low) on light trading volume (0.1× avg).

Summary

Cellyan Biotechnology Co., Ltd. completed a private placement, raising $6.5 million by issuing 12.5 million Class A ordinary shares and 25 million warrants at a significant discount, leading to substantial potential dilution for existing shareholders.


Key Events · Financing and Capital Events · HKPD

  • Capital Raise Completed

    The company raised approximately $6.5 million through a private placement, closing on March 25, 2026.

  • Significant Share Issuance

    The private placement involved the issuance of 12,499,986 Class A ordinary shares.

  • Heavy Warrant Coverage

    Investors also received 24,999,972 warrants (two per share), each exercisable at $0.01 per share for a three-year term.

  • Discounted Pricing

    Units, consisting of one Class A ordinary share and two warrants, were sold at a purchase price of $0.52 per unit, which is below the current market price of $0.62 per share.


Analysis · HKPD · Trade & Services

Cellyan Biotechnology Co., Ltd. has completed a significant private placement, raising $6.5 million. While this capital infusion is crucial for business expansion, working capital, and general corporate purposes, especially following recent negative earnings and a Nasdaq deficiency notice, the terms are highly dilutive for existing shareholders. The offering involved issuing 12.5 million Class A ordinary shares along with 25 million warrants, each exercisable at a very low price of $0.01 per share. The units were sold at a notable discount to the current market price, and the substantial number of warrants with a low exercise price presents a considerable overhang and potential for further dilution upon exercise, which could exert significant downward pressure on the stock.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HKPD was trading at $0.62 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.58 to $2.76. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HKPD - Latest Insights

HKPD
Sep 09, 2026, 8:55 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.1278
Real-time Price: $0.1189 info
Change: -$0.0089 (-7%) info
Market Cap: $1.375M info
HKPD
Aug 07, 2026, 4:30 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.420
Real-time Price: $0.1189 info
Change: -$0.3011 (-72%) info
Market Cap: $1.375M info
HKPD
Jul 16, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5374
Real-time Price: $0.1189 info
Change: -$0.4185 (-78%) info
Market Cap: $1.375M info
HKPD
Jun 12, 2026, 4:30 PM EDT
Filing Type: F-3
Importance Score:
9
Price at Filing: $0.420
Real-time Price: $0.1189 info
Change: -$0.3011 (-72%) info
Market Cap: $1.375M info
HKPD
Mar 27, 2026, 3:19 PM EDT
Filing Type: F-1
Importance Score:
9
Price at Filing: $0.690
Real-time Price: $0.1189 info
Change: -$0.5711 (-83%) info
Market Cap: $1.375M info